Physician profile
Shivam Saxena
NPI 1821484353
$18,217.36
in general payments reported to CMS, 2019-2025
22 companies · $1,798 in 2025
The $1,798 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,468 · 2020: $2,172 · 2021: $753 · 2022: $6,135 · 2023: $1,646 · 2024: $2,245 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,978 · Travel and Lodging: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,977.74 |
| Travel and Lodging | $711.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,124.75 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Medtronic Vascular, INC. | $4,221.50 | 2019-2020 | |
| Philips North America LLC | $3,553.44 | 2019-2022 | |
| Boston Scientific Corporation | $1,856.38 | 2019-2025 | Farapulse, Vigilant X4 Crt-D, Emblem Mri S-Icd |
| Biosense Webster, INC. | $558.30 | 2023-2025 | Carto 3, Qdot Micro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $491.51 | 2019-2021 | |
| Abbott Laboratories | $311.27 | 2023-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Astellas Pharma US INC | $307.69 | 2019-2021 | |
| Pfizer INC. | $257.34 | 2019-2025 | |
| Biotronik INC. | $238.28 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Novo Nordisk INC | $222.06 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $214.32 | 2024-2025 | |
| Abiomed | $201.65 | 2021-2024 | Impella |
| Cardiovascular Systems INC. | $152.58 | 2020 | |
| Preventice Services, LLC | $132.95 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $116.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $71.27 | 2020-2021 | |
| Ge Healthcare | $66.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $44.70 | 2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.69 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $17.14 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $16.07 | 2024 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivam Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.